Tag Archives: Earnings

Mylan Q1 2017 Earnings Update

On May 10th, Mylan hosted its Q1 2017 earnings call and briefly discussed its insulin glargine development program.

This content is for Read Less members only.
Register

Already a member? Log in here

Lexicon Q1 ’17 Earnings Update

Lexicon hosted its Q1 earnings call and provided updates to their T1DM and T2DM diabetes development programs for sotagliflozin and LX2761.

This content is for Read Less members only.
Register

Already a member? Log in here

Lilly Q1 ’17 Earnings Update

Lilly hosted its Q1 ’17 earnings call and provided an update to its diabetes portfolio including pipeline and LCM activities.

This content is for Read Less members only.
Register

Already a member? Log in here

J&J Q1 ’17 Earnings Update

J&J presented its Q1 ’17 earnings results and provided a brief update to its diabetes business including drugs and devices. Of note, J&J is hosting its Pharmaceutical Business Review on May 17.

This content is for Read Less members only.
Register

Already a member? Log in here

Lexicon Q4 ’16 Earnings Update

Lexicon hosted its Q4 and full-year 2016 earnings call and provided an update to its diabetes pipeline.

This content is for Read Less members only.
Register

Already a member? Log in here

Mylan Q4 ’16 Earnings and Investor Day Update

Mylan hosted its Q4 and full-year 2016 earnings call in conjunction with its investor day and provided an update to the insulin pipeline.

This content is for Read Less members only.
Register

Already a member? Log in here

Merck Q4 ’16 Earnings Update

Merck hosted their Q4 and full-year 2016 earnings update today. Overall, there was minimal diabetes-related discussion as the primary focus was on Keytruda.

This content is for Read Less members only.
Register

Already a member? Log in here